Long-term survival after aortic valve replacement for native active infective endocarditis.

Pompilio, G;Brockmann, C;Bruneau, M;Buche, Michel;Schoevaerdts, Jean-Claude;et.al.
(1998) Cardiovascular Surgery — Vol. 6, n° 2, p. 126-132 (1998)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 744.64 KB

Details

Authors
  • Pompilio, G
    Author
  • Brockmann, C
    Author
  • Bruneau, M
    Author
  • Buche, MichelUCLouvain
    Author
  • Louagie, YvesUCLouvain
    Author
  • Author
  • Rubay, JeanUCLouvain
    Author
  • Jamart, JacquesUCLouvain
    Author
  • Schoevaerdts, Jean-ClaudeUCLouvain
    Author
Show more
Abstract
BACKGROUND: The objective of this study was to analyse the impact of acute surgery for native aortic valve endocarditis and its influence on the long-term prognosis after surgery. METHODS: A total of 161 patients underwent aortic valve replacement for native active aortic valve endocarditis (NAAVE) during a 29-year period, from 1967 to 1995 (age range: 10 to 72 years; mean 48 +/- 12). The main indication for surgery was progressive congestive heart failure (76%). Other indications were untreatable sepsis (27%), peripheral or central emboli (12%) and, from 1978, echocardiographic evidence of friable, pedunculated vegetations (3%). Streptococcal and staphylococcal infections predominated. Concomitant procedures were performed in 27% of the patients, including mitral and tricuspid valve surgery and coronary bypass procedures. RESULTS: Operative mortality was 8% in the majority of cases caused by heart failure or multi-organ failure. Multivariate logistic regression analysis identified NYHA class IV to be an independent predictor for postoperative death. Long-term survival for discharged patients was 75% at 10 years and 58% at 15 years, with a mortality rate of 3.6%/patient/year. Cox regression analysis identified the year of operation, trivalvular endocarditis and staphylococcal infection as independent predictors of survival. At 10 and 15 years after aortic valve replacement, 91% and 84% of the patients, respectively, were free of recurrent endocarditis. The presence of an abscess cavity at first operation was found to be predictive of recurrent endocarditis. CONCLUSIONS: Valve replacement for NAAVE offers a good chance for a cure and satisfactory long-term survival. Improvements in pre- and per-operative management of the very ill patient, and the use of allograft valves are likely to further improve long-term results. Finally, the presence of staphylococcal endocarditis requires long-term postoperative antibiotic therapy.
Affiliations

Citations

Pompilio, G., Brockmann, C., Bruneau, M., Buche, M., Amrani, M., Louagie, Y., Eucher, P., Rubay, J., Jamart, J., Dion, R., & Schoevaerdts, J.-C. (1998). Long-term survival after aortic valve replacement for native active infective endocarditis. Cardiovascular Surgery, 6(2), 126-132. https://doi.org/10.1016/S0967-2109(97)00139-7 (Original work published 1998)